Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
8.21
-0.16 (-1.91%)
May 26, 2026, 4:00 PM EDT - Market closed
Upstream Bio Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Upstream Bio stock has a consensus rating of "Buy" and an average price target of $42.43. The average 1-year stock price forecast is 416.81% higher than the current stock price, while the lowest is $15 (+82.70%) and the highest is $75 (+813.52%).
Price Target: $42.43 (+416.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Upstream Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 19, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $42 | Buy | Maintains | $42 | +411.57% | May 19, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $51 → $50 | Buy | Maintains | $51 → $50 | +509.01% | May 14, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $43 | Buy | Maintains | $43 | +423.75% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
Financial Forecast
Revenue This Year
2.03M
from 2.85M
Decreased by -28.94%
Revenue Next Year
1.71M
from 2.03M
Decreased by -15.58%
EPS This Year
-2.95
from -2.66
EPS Next Year
-3.01
from -2.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.2M | 3.7M | ||||||
| Avg | 2.0M | 1.7M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 47.2% | 84.3% | ||||||
| Avg | -28.9% | -15.6% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.53 | -2.54 | ||||||
| Avg | -2.95 | -3.01 | ||||||
| Low | -3.30 | -3.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.